Thorne Healthtech, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q3 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Thorne Healthtech, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q3 2020 to Q2 2023.
  • Thorne Healthtech, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending June 30, 2023 was $72.7M, a 33.1% increase year-over-year.
  • Thorne Healthtech, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending June 30, 2023 was $258M, a 25.5% increase year-over-year.
  • Thorne Healthtech, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $229M, a 24.1% increase from 2021.
  • Thorne Healthtech, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $184M, a 33.1% increase from 2020.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $258M $72.7M +$18.1M +33.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $240M $65.2M +$11.2M +20.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $229M $61.6M +$12.7M +26% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $216M $58.4M +$10.4M +21.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $206M $54.6M +$11.8M +27.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $194M $54M +$9.55M +21.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $184M $48.9M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $48M +$9.24M +23.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $42.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $44.5M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $38.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.